product_name,total_articles,analysis_period,avg_daily_articles,max_daily_articles,dominant_category,dominant_percentage,category_기업소식,category_병원발행,category_연예인,category_투자·주식,category_고객반응,category_기술자료,category_의학,category_기타,campaign_intensity,campaign_score,spike_dates_count,peak_date,peak_articles,number_promotion_articles,unique_numbers_count,celebrity_usage,marketing_keyword_score,competitor_mentions_count,top_competitor_mentioned,competitor_mentions_detail
볼뉴머,71,2025-08-05 ~ 2025-09-02,4.7,21,기업소식,74.6,74.6,2.8,9.9,12.7,0,0,0.0,0.0,HIGH,0.8,3,2025-08-11,21,30,21,없음,67,3,슈링크,울쎄라(3); 슈링크(54); 올리지오(2)
울쎄라,100+,2025-08-12 ~ 2025-09-02,5.0,19,병원발행,73.0,21.0,73.0,5.0,0.0,0,0,1.0,0.0,MEDIUM,0.6,1,2025-09-01,19,12,8,전지현(18); 이민호(18); 김태희(2),49,6,울쎄라,울쎄라(142); 써마지(48); 인모드(9); 슈링크(16); 볼뉴머(3); 올리지오(3)
세르프,52,2025-08-04 ~ 2025-09-01,3.7,24,기업소식,57.7,57.7,38.5,3.8,0.0,0,0,0.0,0.0,MEDIUM,0.6,2,2025-08-21,24,0,0,없음,43,6,울쎄라,울쎄라(5); 써마지(5); 인모드(2); 슈링크(5); 볼뉴머(3); 올리지오(1)
올리지오,52,2025-08-05 ~ 2025-08-29,3.2,10,기업소식,46.2,46.2,44.2,9.6,0.0,0,0,0.0,0.0,MEDIUM,0.6,2,2025-08-19,10,6,9,없음,35,5,슈링크,울쎄라(5); 써마지(3); 인모드(4); 슈링크(12); 볼뉴머(2)
덴서티,40,2025-08-08 ~ 2025-09-02,3.6,13,기업소식,40.0,40.0,27.5,25.0,5.0,0,0,0.0,2.5,MEDIUM,0.6,2,2025-08-12,13,1,3,없음,34,6,인모드,울쎄라(3); 써마지(3); 인모드(4); 슈링크(3); 볼뉴머(1); 올리지오(3)
인모드,40,2025-08-04 ~ 2025-09-01,2.2,11,병원발행,52.5,35.0,52.5,2.5,2.5,0,0,5.0,2.5,MEDIUM,0.6,1,2025-09-01,11,1,4,수지(1),3,4,슈링크,울쎄라(12); 써마지(11); 슈링크(15); 올리지오(4)
슈링크,33,2025-08-04 ~ 2025-09-02,1.8,6,병원발행,81.8,15.2,81.8,0.0,0.0,0,0,3.0,0.0,MEDIUM,0.6,2,2025-08-14,6,0,0,수지(1),1,6,슈링크,울쎄라(22); 써마지(12); 인모드(12); 슈링크(32); 볼뉴머(4); 올리지오(10)
리니어지,29,2025-08-12 ~ 2025-09-02,4.1,12,기업소식,75.9,75.9,17.2,6.9,0.0,0,0,0.0,0.0,MEDIUM,0.6,2,2025-08-12,12,1,2,없음,37,5,써마지,울쎄라(3); 써마지(4); 인모드(3); 슈링크(2); 올리지오(1)
텐써마,23,2025-08-06 ~ 2025-09-01,2.6,11,기업소식,52.2,52.2,43.5,4.3,0.0,0,0,0.0,0.0,MEDIUM,0.6,1,2025-08-18,11,0,0,없음,25,3,슈링크,울쎄라(2); 써마지(1); 슈링크(3)
텐쎄라,15,2025-08-13 ~ 2025-08-28,3.0,11,기업소식,66.7,66.7,26.7,6.7,0.0,0,0,0.0,0.0,MEDIUM,0.6,1,2025-08-18,11,0,0,없음,24,5,인모드,울쎄라(1); 써마지(1); 인모드(2); 슈링크(2); 올리지오(1)
써마지,76,2025-08-04 ~ 2025-09-01,3.2,7,병원발행,86.8,7.9,86.8,2.6,0.0,0,0,2.6,0.0,LOW,0.3,1,2025-08-27,7,4,9,전지현(2); 김태희(2); 수지(1),4,5,써마지,울쎄라(65); 써마지(91); 인모드(8); 슈링크(11); 올리지오(2)
쿨소닉,12,2025-08-05 ~ 2025-08-19,4.0,8,기업소식,66.7,66.7,16.7,8.3,8.3,0,0,0.0,0.0,LOW,0.3,1,2025-08-13,8,7,2,없음,7,1,울쎄라,울쎄라(2)
쿨페이즈,12,2025-08-13 ~ 2025-08-25,4.0,8,기업소식,66.7,66.7,0.0,8.3,16.7,0,0,0.0,8.3,LOW,0.3,1,2025-08-13,8,7,2,없음,9,0,없음,없음
튠페이스,7,2025-08-04 ~ 2025-09-01,1.2,2,병원발행,85.7,14.3,85.7,0.0,0.0,0,0,0.0,0.0,NONE,0.0,0,2025-09-01,2,0,0,수지(1),0,5,써마지,울쎄라(4); 써마지(5); 인모드(1); 슈링크(4); 올리지오(2)
리프테라,4,2025-08-07 ~ 2025-08-27,1.0,1,병원발행,75.0,0.0,75.0,0.0,25.0,0,0,0.0,0.0,NONE,0.0,0,2025-08-07,1,0,0,없음,0,1,올리지오,올리지오(1)
브이로,3,2025-08-08 ~ 2025-08-25,1.0,1,병원발행,66.7,33.3,66.7,0.0,0.0,0,0,0.0,0.0,NONE,0.0,0,2025-08-08,1,1,2,수지(2),0,2,올리지오,슈링크(1); 올리지오(2)
리니어펌,1,2025-08-19 ~ 2025-08-19,1.0,1,병원발행,100.0,0.0,100.0,0.0,0.0,0,0,0.0,0.0,NONE,0.0,0,2025-08-19,1,0,0,없음,0,2,슈링크,슈링크(1); 볼뉴머(1)
튠라이너,0